Exposure assessment at the workplace: Implications of biological variability

Toxicology Letters

Volumn 168, Issue 3, 2007, Pages 210-218

  Manini, Paola ^a   De Palma, Giuseppe ^a   Mutti, Antonio ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Biological monitoring; Biomarkers; Variability; Workers

Indexed keywords

BIOLOGICAL MARKER; PROTEIN; VOLATILE AGENT;

ARTICLE; BIOLOGICAL MONITORING; DNA ADDUCT; HUMAN; METABOLITE; OCCUPATIONAL EXPOSURE; PLANNING; PRIORITY JOURNAL; QUANTITATIVE STUDY; SAMPLING; URINE LEVEL; VALIDATION PROCESS; WORKPLACE;

AIR POLLUTANTS, OCCUPATIONAL; BIOLOGICAL MARKERS; ENVIRONMENTAL MONITORING; HUMANS; OCCUPATIONAL EXPOSURE; WORKPLACE;

BOVINE LEUKEMIA VIRUS;

EID: 33846238574     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2006.09.014     Document Type: Article

References (44)

1. Albertini R.J. Developing sustainable studies on environmental health. Mutat. Res. 480-481 (2001) 317-331
2. ACGIH. American Conference of Governmental Industrial Hygienists. Threshold Limit Values (TLVs) for Chemical Substances and Physical Agents and Biological Exposure Indices (BEIs). Cincinnati, OH (2004)
3. Aitio A., and Apostoli P. Quality assurance in biomarker measurements. Toxicol. Lett. 77 (1995) 195-204
4. Allen B.C., Kavlock R.J., Kimmel C.A., and Faustman E.M. Dose response assessment for developmental toxicity. II Comparison of generic benchmark dose estimates with NOAELs. Fundam. Appl. Toxicol. 23 (1994) 487-495
5. Apostoli P., Maranelli G., Duca P.G., Bavazzano P., Bortoli A., Cruciatti A., Elia G., Minoia C., Piccinini R., Sabbioni E., Sciarra G., and Soave C. Reference values of urinary chromium in Italy. Int. Arch. Occup. Environ. Health 70 (1997) 173-179
6. Berlin A., Yodaiken R.E., and Logan D.C. International Seminar on the Assessment of Toxic Agents at the Workplace Roles of Ambient and Biological Monitoring, Summary report. Luxembourg, 8-12 December, 1980. Int. Arch. Occup. Environ. Health 50 (1982) 197-207
7. Bernard A. Biokinetics and stability aspects of biomarkers: recommendations for application in population studies. Toxicology 101 (1995) 65-71
8. Calleman C.J., Wu Y., He F., Tian G., Bergmark E., Zhang S., Deng H., Wang Y., Crofton K.M., Fennell T., and Costa L.G. Relationship between biomarkers of exposure and neurological effects in a group of workers exposed to acrylamide. Toxicol. Appl. Pharmacol. 126 (1994) 361-371
9. De Palma G., Manini P., Mozzoni P., Andreoli R., Bergamaschi E., Cavazzini S., Franchini I., and Mutti A. Polymorphism of xenobiotic-metabolizing enzymes and excretion of styrene-specific mercapturic acids. Chem. Res. Toxicol. 14 (2001) 1393-1400
10. DFG. Deutsche Forschungsgemainschaft, List of MAK and BAT values. (2004), Wiley-VCH Verlag, Weinheim
11. Filipsson A.F., Sand S., Nilsson J., and Victorin K. The benchmark dose method-review of available models, and recommendations for application in health risk assessment. Crit. Rev. Toxicol. 33 (2003) 505-542
12. Godschalk R.W.L., Van Schooten F.-J., and Bartsch H. A critical evaluation of DNA adducts as biological markers for human exposure to polycyclic aromatic hydrocarbons. J. Biochem. Mol. Biol. 36 (2003) 1-11
13. Haufroid V., Buchet J.-P., Gardinal S., Ghittori S., Imbriani M., Hirvonen A., and Lison D. Importance of genetic polymorphisms of drug-metabolizing enzymes for the interpretation of biomarkers of exposure to styrene. Biomarkers 6 (2001) 236-249
14. Henderson R.F., Bechtold W.E., Bond J.A., and Sun J.D. The use of biological markers in toxicology. Crit. Rev. Toxicol. 20 (1989) 65-82
15. Imbriani M., and Ghittori S. Gases and organic solvents in urine as biomarkers of occupational exposure: a review. Int. Arch. Occup. Environ. Health 78 (2005) 1-19
16. IPCS, 2001. International Programme on Chemical Safety. Environmental Health Criteria 222, Biomarkers in Risk Assessment: Validity and Validation. World Health Organization, Geneva, pp. 1-29.
17. Jakubowski M., and Trzcinka-Ochocka M. Biological monitoring of exposure: trends and key developments. J. Occup. Health 47 (2005) 22-48
18. Koc H., and Swenberg J. Application of mass spectrometry for quantitation of DNA adducts. J. Chromatogr. B 778 (2002) 323-343
19. Lauwerys R.R., and Hoet P. Industrial Chemical Exposure. Guidelines for Biological Monitoring. second ed. vol. 1 (1993), Lewis Publishers, Boca Raton 5
20. Liljelind I., Rappaport S., Eriksson K., Andresson J., Bergdahl I.A., Sunesson A.-L., and Järvholm B. Exposure assessment of monoterpenes and styrene: a comparison of air sampling and biomonitoring. Occup. Environ. Med. 60 (2003) 599-603
21. Manini P., Andreoli R., Bergamaschi E., De Palma G., Mutti A., and Niessen W.M.A. A new method for the analysis of styrene mercapturic acids by liquid chromatography/electrospray tandem mass spectrometry. Rapid Commun. Mass Spectrom. 14 (2000) 2055-2060
22. Manini P., De Palma G., Andreoli R., Goldoni M., and Mutti A. Determination of urinary styrene metabolites in the general Italian population by liquid chromatography-tandem mass spectrometry. Int. Arch. Occup. Environ. Health 77 (2004) 433-436
23. Manini P., Andreoli R., and Niessen W.M.A. Liquid chromatography-mass spectrometry in occupational toxicology: a novel approach to the study of biotransformation of industrial chemicals. J. Chromatogr. A 1058 (2004) 21-37
24. Manini P., De Palma G., Andreoli R., Poli D., Mozzoni P., Folesani G., Mutti A., and Apostoli P. Environmental and biological monitoring of benzene exposure in a cohort of Italian taxi drivers. Toxicol. Lett. 167 (2006) 142-151
25. Minoia C., and Apostoli P. Activity of the Italian society of reference values. Int. Arch. Occup. Environ. Health 72 (1999) 268-270
26. Mürer A.J.L., Christensen J.M., and Midtgaard T. Determination of urinary metabolites of styrene: estimation of the method evaluation function and evaluation of reference values in Danish subjects. Int. Arch. Occup. Environ. Health 65 (1994) 313-318
27. Mutti A. Detection of renal diseases in humans: developing markers and methods. Toxicol. Lett. 46 (1989) 177-191
28. Mutti A. Biomarkers of exposure and effect for non-carcinogenic end-points. International Programme on Chemical Safety. Environmental Health Criteria 222, Biomarkers in Risk Assessment: Validity and Validation vol. 104 (2001), World Health Organization, Geneva 130-136
29. Mutti A. Preface. Toxicol. Lett. 134 (2002) 1-2
30. NRC, National Research Council. Biological markers in environmental health research Environ. Health Perspect. 74 (1987) 3-9
31. Pierrehumbert G., Droz P.-O., Tardif R., Charest-Tardif G., and Truchon G. Impact of human variability on the biological monitoring of exposure to toluene, phenol, lead, and mercury: II Compartmental based toxicokinetic modelling. Toxicol. Lett. 134 (2002) 165-175
32. Riis B. Comparison of results from different laboratories in measuring 8-oxo-2′-deoxyguanosine in synthetic oligonucleotides. Free Radic. Res. 36 (2002) 649-659
33. Rojas M., Alexandrov K., Auburtin G., Wastiaux-Denamur A., Mayer L., Mahieu B., Sebastien P., and Bartsch H. Anti-benzo[a]pyrene diolepoxide-DNA adducts levels in peripheral mononuclear cells from coke-oven workers and the enhancing effect of smoking. Carcinogenesis 16 (1995) 1373-1376
34. Schaller K.H., Angerer J., and Drexler H. Quality assurance of biological monitoring in occupational and environmental medicine. J. Chromatogr. B 778 (2002) 403-417
35. SCOEL, Scientific Committee group on Occupational Exposure Limits, 2005. Proposal for biomonitoring. European Commission. Directorate-General for Employment, Industrial Relations and Social Affairs.
36. Setzer R.W., and Kimmel C.A. Use of NOAEL, benchmark dose, and other models for human risk assessment of hormonally active substances. Pure Appl. Chem. 75 (2003) 2151-2158
37. Symanski E., Bergamaschi E., and Mutti A. Inter- and intra-individual sources of variation in levels of urinary styrene metabolites. Int. Arch. Occup. Environ. Health 74 (2001) 336-344
38. Soldberg H.E. Approved recommendation on the theory of reference values Part 5. Statistical treatment of collected reference values. Determination of reference limits. Clin. Chim. Acta 170 (1987) S13-S32
39. Tardif R., Droz P.-O., Charest-Tardif G., Pierrehumbert G., and Truchon G. Impact of human variability on the biological monitoring of exposure to toluene: I. Physiologically based toxicokinetic modelling. Toxicol. Lett. 134 (2002) 155-163
40. Törnqvist M., Fred C., Haglund J., Hellenberg H., Paulsson B., and Rydberg P. Protein adducts: quantitative and qualitative aspects of their formation, analysis and applications. J. Chromatogr. B 778 (2002) 279-308
41. Valkonen S., and Kallio A. Finnish quality assurance programme for biological monitoring of organic solvents. J. Chromatogr. B 778 (2002) 419-427
42. Viau C. Biological monitoring of exposure to mixtures. Toxicol. Lett. 134 (2002) 9-16
43. Viau C., Diatiké A., Ruzgyté A., Tuchweber B., Blais C., Bouchard M., and Vyskocil A. Is 1-hydroxypyrene a reliable bioindicator of measured dietary polycyclic aromatic hydrocarbon under normanl conditions?. J. Chromatogr. B 778 (2002) 165-177
44. Watson W.P., and Mutti A. Role of biomarkers in monitoring exposure to chemicals: present position, future prospects. Biomarkers 9 (2004) 211-242